Immunotherapy combinations tested in pMMR/MSS rectal cancer
Skip to content
The CRC Digest
Immunotherapy combinations tested in pMMR/MSS rectal cancer
Meta-analysis evaluates immune checkpoint inhibitor-based neoadjuvant therapy for proficient mismatch repair and microsatellite stable locally advanced rectal tumors. (Clinical Colorectal Cancer)
This content is informational only and does not constitute medical advice.
Always consult your oncologist